Rectal administration of d-alpha tocopherol for active ulcerative colitis: A preliminary report

doi:10.3748/wjg.14.5990

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4757)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

409

HTML

4116

Figures (1-4)

232

Sum=4757

Oct 21, 2008 (publication date) through Aug 26, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Oct 21, 2008; 14(39): 5990-5995
Published online Oct 21, 2008. doi: 10.3748/wjg.14.5990

Full Size Figure Download Figure

Figure 3 Change in the modified DAI. A modified DAI score, including all components of the complete DAI other than the endoscopic appearance is calculated at each observation point. By week 4 the mean modified DAI score significantly decreased compared to baseline (week 0) scores. ^aP < 0.0001 vs baseline.

Citation: Mirbagheri SA, Nezami BG, Assa S, Hajimahmoodi M. Rectal administration of d-alpha tocopherol for active ulcerative colitis: A preliminary report. World J Gastroenterol 2008; 14(39): 5990-5995
URL: https://www.wjgnet.com/1007-9327/full/v14/i39/5990.htm
DOI: https://dx.doi.org/10.3748/wjg.14.5990